CD47 and neoplasm: We investigated the effect of anti-CD47 in patient-derived PDAC xenografts and studied the mechanism of such effect using single-cell RNA-sequencing (scRNA-seq), a high dimensional profiling to evaluate functional and genetic changes of tumor-infiltrating immune cell populations of syngeneic mouse models following CD47 targeting.